CX 2024 Programme
Day 1: Peripheral Arterial Controversies - Tuesday, 23rd April
Venue: Theatre 1
Time: 08:00 - 18:00
Paclitaxel Mortality Controversy - Tuesday, 23rd April
Time: 08:00 - 08:45
| Anchor: | Andrew Holden, Auckland, New Zealand |
| Moderators: | Sahil Parikh, New York, United States |
| Marianne Brodmann, Graz, Austria | |
| Barry Katzen, Miami, United States |
09:50 - 09:55
Debate: After the FDA announcement, paclitaxel-coated devices now beat limus-coated devices - Tuesday, 23rd April
For the motion
09:50 - 09:55
| Andrew Holden, Auckland, New Zealand |
11:05 - 11:10
The multi-element balloon expandable bioresorbable vascular scaffold system in the SFA - Tuesday, 23rd April
| Speaker: | Andrew Holden, Auckland, New Zealand |
11:45 - 11:50
Intravascular lithotripsy in BTK arteries: Data and new technologies - Tuesday, 23rd April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Deep Venous Arterialisation - Tuesday, 23rd April
Time: 13:30 - 14:35
| Anchor: | Robert Hinchliffe, Bristol, United Kingdom |
| Moderators: | Thomas Zeller, Bad Krozingen, Germany |
| Andrew Holden, Auckland, New Zealand |
14:45 - 14:50
An update of the FORWARD clinical study comparing uncovered to covered stents in the iliac arteries - Tuesday, 23rd April
| Speaker: | Andrew Holden, Auckland, New Zealand |
BASIL-3 Podium First Presentation - Tuesday, 23rd April
Time: 16:10 - 18:00
| Anchor: | Andrew Holden, Auckland, New Zealand |
| Moderators: | Dittmar Boeckler, Heidelberg, Germany |
| Robert Hinchliffe, Bristol, United Kingdom |
Day 1 Morning: Vascular Access Masterclass Controversies - Tuesday, 23rd April
Venue: Theatre 3
Time: 08:00 - 13:00
12:30 - 12:35
Podium First: IN.PACT AV Access outcomes. We know which DCB to use! - Tuesday, 23rd April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Day 3 Morning: Juxtarenal Controversies - Thursday, 25th April
Venue: Theatre 1
Time: 08:00 - 13:00
Juxtarenal Controversies - Thursday, 25th April
Time: 08:00 - 10:10
| Anchor: | Andrew Holden, Auckland, New Zealand |
| Moderators: | Fiona Rohlffs, Regensburg, Germany |
| Bijan Modarai, London, United Kingdom |
09:10 - 09:15
Podium First: A new endoanchor system for enhanced endograft fixation and seal - Thursday, 25th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Day 3 Afternoon: Abdominal Aortic Aneurysm Controversies - Thursday, 25th April
Venue: Theatre 1
Time: 13:00 - 18:00
14:25 - 14:30
Growth stabilising therapy for small to medium-sized AAA: Clinical data from a first-in-human study - Thursday, 25th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
16:55 - 17:00
Debate: New polymer-based aneurysm sac management is the future and differs from previously failed polymer-based technologies - Thursday, 25th April
For the motion
16:55 - 17:00
| Andrew Holden, Auckland, New Zealand |
Day 2 Afternoon: Peripheral Techniques & Technologies - Wednesday, 24th April
Venue: Theatre 3
Time: 13:30 - 15:20
14:00 - 14:05
Podium First: First look at the PREVISION FIH Trial evaluating the novel sirolimus DCB catheter - Wednesday, 24th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Day 3: CX Innovation Showcase - Thursday, 25th April
Venue: Theatre 3
Time: 09:00 - 18:00
17:35 - 17:40
A new endoanchor system for enhanced endograft fixation and seal - Thursday, 25th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Day 2: Vascular Access & Peripheral Case Presentations - Wednesday, 24th April
Venue: Presentation Zone, CX Workshop Area
Time: 09:00 - 18:00
13:30 - 13:40
Real world use of Shockwave IVL - Wednesday, 24th April
| Speaker: | Andrew Holden, Auckland, New Zealand |